- $808.98m
- $791.39m
- $169.33m
- 90
- 25
- 80
- 71
Annual income statement for Atrion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 155 | 148 | 165 | 184 | 169 |
| Cost of Revenue | |||||
| Gross Profit | 70.7 | 66.2 | 69.4 | 75.9 | 62.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 115 | 112 | 129 | 144 | 147 |
| Operating Profit | 40.5 | 35.7 | 36 | 39.7 | 22.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 43.2 | 38.5 | 38.4 | 40.6 | 22.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 36.7 | 32.1 | 33.1 | 35 | 19.4 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 36.8 | 32.1 | 33.1 | 35 | 19.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 36.8 | 32.1 | 33.1 | 35 | 19.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 19.7 | 17.4 | 18.2 | 19.6 | 11 |
| Dividends per Share |